iBio, Inc.IBIONYSE
Loading
Operating Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-22.97M
↓ 11% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-20.67M
Historical baseline
PeriodValueYoY Change
TTM$-22.97M-23.5%
2025$-18.60M-11.8%
2024$-16.63M+43.3%
2023$-29.34M+1.2%
2022$-29.70M+4.5%
2021$-31.11M-122.2%
2020$-14.00M+11.3%
2019$-15.79M-11.0%
2018$-14.23M+0.3%
2017$-14.27M-